Abstract:In situ glyco-editing on the cell surface can endow cellular glycoforms with new structures and properties; however, the lack of cell specificity and dependence on cells' endogenous functions plague the revelation of cellular glycan recognition properties and hamper the application of glyco-editing in complicated authentic biosystems. Herein, we develop a thermally triggered, cell-specific glyco-editing method for regulation of lectin recognition on target live cells in both single- and cocultured settings. The method relies on the aptamer-mediated anchoring of microgel-encapsulated neuraminidase on target cells and subsequent thermally triggered enzyme release for localized sialic acid (Sia) trimming. This temperature-based enzyme accessibility modulation strategy exempts genetic or metabolic engineering operations and, thus for the first time, enables tumor-specific desialylation on complicated tissue slices. The proposed method also provides an unprecedented opportunity to potentiate the innate immune response of natural killer cells toward target tumor cells through thermally triggered cell-specific desialylation, which paves the way for in vivo glycoimmune-checkpoint-targeted cancer therapeutic intervention.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c15212?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c15212</a>.Experimental section; scheme for preparation of thermally sensitive MG; evaluation of the influence from MG on detection of Neu concentration and Neu activity; effect of temperature on the Neu activity; study of the effects of various components or probes on cell viability; exclusion of the effects of F127, F127-LA, F127-LA-DA, and MG on Neu activity; demonstration of Apt binding specificity of @Apt toward MDA-MB-231 cells; optimization of experimental conditions for @Apt-based Sia trimming; analysis of the average amount of Neu released from cell-bound @Apt per cell; flow cytometric verification of cell-specific glyco-editing in cocultured cell setting; tumor-specific glyco-editing on tissue slices from subcutaneous MDA-MB-231 xenografts and normal breast tissues; demonstration of cell specificity of @Apt-based Sia trimming using bladder tumor tissue slices; demonstration of the successful isolation of NK cells from PBMCs; cell viability of separately cultured MDA-MB-231 and MCF-7 cells after incubation with NK cells; and flow cytometric verification of cell-specific potentiation of NK cell killing activity in cocultured cell setting (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c15212/suppl_file/am0c15212_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Thermally Triggered, Cell-Specific Enzymatic Glyco-Editing: <i>In Situ</i> Regulation of Lectin Recognition and Immune Response on Target Cells

Thermally Triggered, Cell-Specific Enzymatic Glyco-Editing: In Situ Regulation of Lectin Recognition and Immune Response on Target Cells

Chemical Remodeling Cell Surface Glycans for Immunotargeting of Tumor Cells

Targeting Tumor Cells by Natural Anti-Carbohydrate Antibodies Using Rhamnose-Functionalized Liposomes.

Modulating Cell-Surface Receptor Signaling and Ion Channel Functions by In Situ Glycan Editing.

Specifically Editing Cancer Sialoglycans for Enhanced Immunotherapy In Vivo through Aptamer‐Enzyme Chimeras

Selective N-glycan editing on living cell surfaces to probe glycoconjugate function

Traceless Protein-Selective Glycan Labeling and Chemical Modification.

A localized glyco-editing probe for revelation of protein-specific glycan function

A Computational and Chemical Design Strategy for Manipulating Glycan‐Protein Recognition

Switchable Enzymatic Accessibility for Precision Cell-Selective Surface Glycan Remodeling.

Spatiotemporal control of cell-cell reversible interactions using molecular engineering

Bacterial Glycosyltransferase-mediated Cell-surface Chemoenzymatic Glycan Editing: Methods and Applications

Recent Advances in Protein‐Specific Glycan Imaging and Editing

Glycosylation editing: an innovative therapeutic opportunity in precision oncology

Enzyme-Sialylation-Controlled Chemical Sulfation of Glycan Epitopes for Decoding the Binding of Siglec Ligands

In Situ Cellular Glycan Analysis

Surface-Initiated Synthesis of Cell-Specific Glycopolymers Using Live Mammalian Cells As Templates.

In Situ Glycan Analysis and Editing in Living Systems

Abstract IA010: Engineering human sialidase as novel cancer therapeutics by targeting sialoglycans

Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis -Ligands